Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2016-02-11

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2016-02-11

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2016-02-04

View Filing

PRE 14A - Other preliminary proxy statements

Form Type: PRE 14A

Filing Date: 2016-02-01

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2016-01-11

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2016-01-08

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2015-09-17

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2015-09-11

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2015-08-28

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2015-08-26

View Filing